Session 8 ILO's Haemolytic anaemias and Haemoglobinopathies Flashcards

1
Q

Why might anaemia develop?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a haemoglobinopathy?

A
  • A condition where there is abnormal synthesis of the globin chain
  • Inherited disorders typically autosomal recessive
  • Globin gene mutations alter
    structure/function/stability
    of the haemoglobin tetramer

DOUBLE CHECK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do globin chain mutations do?

A

Globin gene mutations reduce expression of specific individual globin proteins resulting in an imbalance in the composition of the haemoglobin tetramer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the science behind sickle cell disease?

A

Abnormal globin chain variants with altered stability and/or function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the science behind thalassaemia?

A

Reduced or absent expression of normal globin chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the significance of sickle cell anaemia and

A

The HbS variant has an uncharged valine instead of a charged glutamic acid, making haemoglobin S more prone to polymerise at low oxygen tension. This leads to the formation of long twisted haemoglobin polymers that can result in the deformation the red blood cell membrane leading to the cell taking on a sickle shape.

After repeated episodes of sickling, damage occurs to the red cell membrane causing it to lose elasticity. Such damaged cells fail to return to a normal shape when normal oxygen tension is restored.

Consequences of sickle cell anaemia:
1. Vaso-occlusive episodes due to occlusion of small capillaries from sickle cells getting trapped
2. Anaemia due to sickle cells undergoing haemolysis resulting in a shortened erythrocyte lifespan from ~120 days to ~20-30 days
3. Jaundice and gallstones due to increased bilirubin resulting from chronic haemolysis
4. Splenic atrophy due to splenic infarction with an associated susceptibility to infection by encapsulated bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Appreciate the clinical manifestations of sickle cell anaemia

A

Clinical manifestations:

  • Due to the vasoocclusive episodes, they can have recurrent acute, severe pain and syndromes such as stroke or acute chest syndrome as well as chronic kidney disease and joint damage from avascular necrosis
  • Classic symptoms from anaemia (e.g. SOB, pale etc.)
  • Jaundice due to increased bilirubin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

To be able to classify haemolytic anaemias into acquired and inherited types, and explain the underlying causes in each division

A

Inherited haemolytic anaemias (caused by a defective gene - come back to the causes when watch lecture):
- Glycolysis defect
- Pentose P pathway
- Membrane protein
- Haemoglobin defect

Acquired haemolytic anaemias (caused by damage to cells):
- Mechanical damage
- Antibody damage
- Oxidant damage
- Heat damage
- Enzymatic damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name the 4 major types of myeloproliferative neoplasm

A
  • Essential Thrombocythaemia
  • Polycythaemia Vera
  • Myelofibrosis
  • Chronic Myeloid Leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe Polycythaemia vera and explain how these arise

A
  1. Polycythaemia vera
    - Due to overproduction of RBCs due to abnormality of bone marrow due to JAK2 V617F mutation (present in 95% of patients)
    - Just polycythaemia is either relative (due to a decrease in plasma volume) or absolute (increase in RBCs)
    - Need to figure out if it is primary (polycythaemia vera) or secondary to another condition
    * Diagnostic criteria = High haematocrit (>0.52 in men, >0.48 in women) OR raised red cell mass
    * JAK2 V617F mutation is present in approximately 95% PRV patients
    * No reactive cause found
    * Some patients also have high platelets & neutrophils
    * Median age 60 yrs
    * Male=Female
  2. Essential thrombocythaemia
    - ET is associated with a proliferation of platelet precursors in the bone marrow, leading to increased platelet production
  3. Myelofibrosis
    - Characterised by haemopoetic-derived clonal proliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations
    - Starts with proliferative phase when all cell counts are high, then pancytopenia occurs due to bone marrow fibrosis and hypersplenism
    - Can be primary disease or secondary to polycythaemia vera or essential thrombocythaemia
  4. Chronic myeloid leukaemia
    - Usually presents with very high white cell count resulting from the uncontrolled proliferation of mature granulocytes and their precursors
    - CML is linked to a genetic abnormality known as the Philadelphia chromosome, which involves a translocation of the chromosome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Essential thrombocythaemia and explain how these arise

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Myelofibrosis and explain how these arise

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Chronic myeloid leukaemia and explain how these arise

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain how acquired thrombocytopenia may arise and appreciate the clinical signs of this condition

A

There are 3 ways in which acquired thrombocytopenia may arise

  1. Decreased platelet production
    - B12 or folate deficiency
    - Acute leukaemia or aplastic anaemia
    - Liver failure
    - Sepsis
    - Cytotoxic chemotherapy
  2. Increased platelet consumption
    - Massive haemorrhage
    - DIC
    - Thrombotic thrombocytopenia purpura
  3. Increase platelet destruction
    - Autoimmune thrombocytopenia purpura
    - Drug induced
    - Hypersplenism (destruction and pooling of platelets)

Clinical signs:
- Only symptomatic after platelet count <30
- Easy bruising
- Petechiae / purpura
- Mucosal bleeding (mouth, back of eye etc.)
- Severe bleeding after trauma
- Intracranial haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the haematological abnormalities of patients with haemoglobinopathies - alpha and beta thalassaemia trait

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the important clinical features of alpha and beta thalassaemia trait

A
17
Q

Explain the complications of alpha and beta thalassaemia trait

A
18
Q

Explain the haematological abnormalities of patients with haemoglobinopathies - thalassaemia major

A
19
Q

Explain the important clinical features of thalassaemia major

A
20
Q

Explain the complications of alpha and beta thalassaemia major

A
21
Q

Explain the haematological abnormalities of patients with haemoglobinopathies - sickle cell disease

A
22
Q

Explain the important clinical features of sickle cell disease

A
23
Q

Explain the complications of sickle cell disease

A
24
Q

Describe the 3 types of sickle cell crises

A

Clinical pattern quite variable
3 types of crises:

  • Vaso-occlusive:
  • Painful bone crises
  • Organ–chest,spleen
  • Aplastic (often triggered by parvovirus)
  • Haemolytic

From all of them: end organ damage occurs as a result of acute thromboses or O2 deprivation

25
Q

What are the clinical features of myeloproliferative disorders?

A
  • Overproduction of one or several blood elements with dominance of a transformed clone.
  • Hypercellular marrow / marrow fibrosis.
  • Cytogenetic abnormalities.
  • Thrombotic and/or haemorrhagic diatheses.
  • Extramedullary haemopoiesis (liver/spleen).
  • Potential to transform to acute leukaemia.
  • Overlapping clinical features.
26
Q

What do all of the myeloproliferative disorders have in common?

A

All of these disorders involve dysregulation at the multipotent haematopoietic stem cell